Group items tagged

The global body armor and personal protection market primarily consists of five categories including soft armor, hard armor, protective headgear, clothing and boots. The global body armor and personal protection market is estimated to value USD 2.4 billion in 2013. It is also anticipated to increase at a CAGR of 4.58% during 2013 to 2023 and peak at USD 3.7 billion by 2023.

Research On Global Markets provides market research reports on various industries according to countries. It also provide you many company profiles according to your requirement. This will help you to understand the latest trends and statistics.

Analysis of the power market scenario in Saudi Arabia in addition to an in-depth study of the active thermal power plants in the country, upcoming thermal installation details, and major equipment market size and company snapshots of some of the major market participants provides a future outlook of the industry with forecasts up to 2025. Key policies and regulatory framework supporting thermal power development assist in identifying key growth and investment opportunities in Saudi Arabia thermal power market. Company snapshots of some of the major market participants in the country facilitate understanding and responding to competitors business structure, strategy and prospects.

Unmet needs in hematologic malignancies calls for companies focusing on PI3Ks and BTK inhibitors to offer better treatment options. Around USD 10 bn has already been invested in licensing and acquisition of PI3K and other kinase inhibitors since the last five years. Targeting kinases have been on the agenda of most drug developers as they hold the key path to signaling, development and growth of the cell. Large global pharma are constantly on the hunt for drugs with label expansion potential, longevity and blockbuster potential.

Treating refractory hematological malignancies unfold a host of competition and commercial opportunities. Approved therapies for AML, MDS, unmet need and limitations of the current SOC for relapsed and refractory pts attract swarming competition. There is severe competition amongst the companies to launch new therapies for this indication. Companies leading in the race to launch such therapies include Ambit Biosciences, Onconova Therapeutics, SymBio Pharma, and Celgene.

The market consists of four major categories of radar systems ground-based, naval, airborne and space-based. The global military radar market is estimated to be valued at USD 9.1 billion in 2013. The value of the market is expected to increase marginally at a CAGR of 1.58% during 2013 to 2023. A comprehensive analysis of the spending and modernization patterns in different regions around the world helps in ascertaining the demand drivers and growth stimulators for the military radar market.

This report, the IT Market in Russia 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the IT market in Russia landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space include ASUSTek Computer Inc., Hewlett Packard Co., IBM Corp., and National Computer Corp.

Dry eye syndrome (DES), or keratoconjunctivitis sicca, is a multifactorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. DES, which is often referred to simply as dry eye, is the most prevalent form of ocular discomfort and irritation. The most common symptoms of DES are ocular irritation and discomfort, foreign body sensation, fatigue, and visual disturbances, which interfere with daily activities. In the elderly population, it is the most common reason for seeking eye care, and this is expected to increase exponentially with an aging demographic.

This report, the LTE Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the LTE market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The prospective market for mattresses exhibits a host of opportunities for mattresses in Qatar. Future outlook, macroeconomic indicators and market trends offer a perspective on the development of the market. Key product segments in the industry comprise mattress supports, cellular rubber and plastic mattresses including other mattresses.

Real estate was the largest asset class for HNWIs in the UAE in 2012, accounting for 23.2% of total HNWI assets. Cash products recorded the strongest growth during 2008 to 2012, driven by a movement to safer assets during the financial crisis. Cash is expected to be the worst performing asset class resulting in a movement away from cash and towards equities.

Market size for gasoline, oil additives by product segment, current market situation and trends unfold a host of opportunities and attract new entrants into the market, which builds up competition for the existing players. Important product segments include Lead compound based anti-knock preparations, other anti-knock preparations, lubricating oil additives with petroleum and bitumen oils, other lubricating oil additives, other gasoline and oil additives.

The German chronic heart failure (CHF) therapeutics market was worth approximately USD 484.7 million in 2012, with a projected compound annual growth rate (CAGR) of 2.4%, to reach a total of USD 614.8 million in 2022. The launch of Novartis' novel combination drug, LCZ-696 in 2015 will mark the first entrance of a novel branded CHF drug in the past five years, boosting the overall market size considerably till 2022.

The retail market in Hong Kong remains a high-potential market, with a CAGR of 8.08% expected between 2012 and 2017. It is predicted that by 2017, the retail market will continue to steadily increase and reach HKD 557.6 billion. Value Retailers are set to contribute to the growth in Hong Kong's retailing market. Hong Kong's retail market is set for healthy growth over the next four years, with a CAGR of 7.84% forecast between 2012 and 2017, which will see the market ultimately valued at HKD 18,466.3 million.

Although the maturity of the UK ready meals market has resulted in static growth in terms of sales value between 2007 and 2012, it is forecasted to grow significantly at a CAGR of 4.7%, between 2012 and 2017. In recent years, much attention has been paid to cooking becoming more common among men: it is no longer viewed as a chore and is more often considered as a life-skill akin to having a successful career, one that can enhance a person's image. However, while this is indeed true to an extent, UK males are still more reliant on ready meals than women. Despite social shifts, and a dominant media presence that has overstated their impact, women are still typically more likely to take on traditional roles within the family home, such as looking after the dietary habits of children and cooking.

The non-existence of effective vaccine against HCV leads the healthcare market in United States to be driven by therapeutics. Vertexs Incivek was amongst the first DAA HCV therapies launched in the US and is the current market leader. Inciveks improved efficacy over the previous standard of care in the treatment of the most prevalent HCV genotype in the US, HCV GT1, which enabled the drug to quickly capture the market. Adverse events associated with Incivek therapy, such as life-threatening skin reactions, and the slow-progressing nature of HCV, has resulted in many patients deciding to forego treatment in order to wait for the launch of a more-tolerable HCV regimen.

The main growth driver for personal accident and health insurance during 2008 to 2012 was the launch of HIV or AIDS insurance by both health and life insurers, which was purchased by a large number of the country's formerly uninsured population. The personal accident and health insurance segment grew at a CAGR of 10.7% during 2008 to 2012. This robust growth was supported by the country's increasing per capita income levels, GDP growth, favorable insurance reforms, and financial and healthcare service expansions.

This report provides the results for the Soy Products market in China from Canadeans unique, highly detailed study of consumers Consumer Packaged Goods (CPG) consumption habits, and forms part of an overall series covering all CPG product markets. Its coverage includes, but is not limited to, consumption behaviors, the extent to which consumer trends influence their consumption, the value of the market these trends influence, and brand and private label choices as well as retailer choices.

Current market situation and trends unveil the future prospects of the electronic component market in Singapore to 2017. Important product segments include cards incorporating a magnetic stripe, cards incorporating an electronic integrated circuit, electrical capacitors, electrical resistors, potentiometers and rheostats, electronic integrated circuits and micro-assemblies, electronic printed circuits, semiconductor devices, thermionic and cold cathode valves and tubes.

With conventional corticosteroid treatment being effective in only 50-60% of patients, development of new treatment options is necessary to cover the unmet needs of the uveitis market. The market is currently dominated by corticosteroid treatment options and off-label immunosuppressive and biologic drugs. Although anterior uveitis patients constitute the major share of patients, except one, all the new treatments in late stage clinical development target the intermediate, posterior and pan uveitis patient segment. Drugs capable of permanently inhibiting ocular inflammation as well as offering an improved safety profile will have a significant impact on the uveitis market.